Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Genocea Biosciences, Inc. (GNCA)

« Back to company index

GNCA Chatter Timeline

Stock Ticker for GNCA

Most Active Tweeters for GNCA

UserTweets
@YVR_Trader 5
@bulletin_en 5
@Tickeron 5
@Lin_ling_88 4
@BeefEnt 4

Recent Tweets for GNCA

Ultra_Calls @Ultra_Calls
$GNCA Due for a nice run. Watching this one closely tomorrow. ?
May 23rd 2019, 5:05pm
registrarjourn @registrarjourn
Genocea Biosciences $GNCA Upgraded to Buy at ValuEngine https://t.co/onInhuXDh5
May 23rd 2019, 2:05am
EnterpriseLeade @EnterpriseLeade
Genocea Biosciences $GNCA Upgraded to Buy at ValuEngine https://t.co/BuweTd8a30
May 23rd 2019, 2:05am
Tickeron @Tickeron
$GNCA Genocea Biosciences (GNCA, $4.75) was the month's biggest loser, shedding -15% https://t.co/SRAkrSANWl
May 23rd 2019, 12:05am
SzhaoTrader @SzhaoTrader
$GNCA Genocea Biosciences 8-K Shows News Of 1-For-8 Reverse Stock Split Effective May 22, 2019. Don’t get confused.
May 22nd 2019, 9:05pm
Lin_ling_88 @Lin_ling_88
Dr.Gottlieb has returned to VC #NEA who owns both $GNCA and $MRKR heavily. No way this is negative. https://t.co/elzZYNMxm9
May 22nd 2019, 6:05pm
rajramaswamy @rajramaswamy
RT @Lin_ling_88: $GNCA $MRKR Ex-FDA Commissioner Dr. Gottlieb has returned to his old gig at NEA; it’s comforting to know NEA remainsTHE to…
May 22nd 2019, 6:05pm
Lin_ling_88 @Lin_ling_88
$GNCA $MRKR Ex-FDA Commissioner Dr. Gottlieb has returned to his old gig at NEA; it’s comforting to know NEA remain… https://t.co/jm57XmSozX
May 22nd 2019, 6:05pm
Tickeron @Tickeron
$GNCA Genocea Biosciences (GNCA, $4.75) was the stock market's top loser yesterday, falling -10.47% https://t.co/6WTkys5NIO
May 22nd 2019, 5:05pm
Tickeron @Tickeron
A.I.dvisor made a bearish call on $GNCA, netting in a 17.91% gain over 6 days https://t.co/YD1sz2otGK https://t.co/mYWINNmOMN
May 22nd 2019, 5:05pm
bulletin_en @bulletin_en
Reviewing Global Cord Blood Corporation $GNCA's results https://t.co/uDOdlHyI5H
May 22nd 2019, 2:05pm
sarkoconsulting @sarkoconsulting
$gnca reverse split check back in a month probably can get it lower #biotech #stocks
May 22nd 2019, 12:05pm
Tickeron @Tickeron
$GNCA Genocea Biosciences (GNCA, $4.75) was this week's top stock market loser, declining -17% https://t.co/FIvRSzIuJW
May 22nd 2019, 10:05am
lukerehmann @lukerehmann
Genocea Biosciences $GNCA performed a 1 for 8 reverse split. Fractional shares resulting from the split will be rou… https://t.co/J9BURudIeZ
May 22nd 2019, 10:05am
Tickeron @Tickeron
$GNCA Genocea Biosciences (GNCA, $4.75) was the market's top quarterly gainer, rising +19% https://t.co/XDtXkrtUbF
May 22nd 2019, 9:05am
BeefEnt @BeefEnt
RT @Stock_News_Now: $GNCA: New SEC Filing for GNCA: Form EFFECT (No. 9999999995-19-001101): https://t.co/fTceUo84x1
May 22nd 2019, 8:05am
BeefEnt @BeefEnt
RT @InsiderBiotech: $GNCA briefly before ASCO https://t.co/KSYuLow3zJ
May 22nd 2019, 8:05am
BeefEnt @BeefEnt
RT @YVR_Trader: $GNCA 1 for 8 R/S effective tomorrow https://t.co/AA7r1O4Rgk
May 22nd 2019, 8:05am
BeefEnt @BeefEnt
RT @SwingTradeBot: 200 DMA Support today: $GNCA $C ... https://t.co/LjP7KUcNnp
May 22nd 2019, 8:05am
bulletin_en @bulletin_en
Rigel Pharmaceuticals Inc. $GNCA Comparing side by side https://t.co/HPvkrMi8eQ
May 21st 2019, 6:05pm
YVR_Trader @YVR_Trader
Who gets bought first $MRKR or $GNCA?
May 21st 2019, 4:05pm
Matthew96240465 @Matthew96240465
$GNCA is coming out with phase 1/2 data for GEN-009 vaccine for various cancers on June 1, 2019 at ASCO. It’s dippe… https://t.co/od0kWACoUZ
May 21st 2019, 10:05am
YVR_Trader @YVR_Trader
$GNCA 1 for 8 R/S effective tomorrow https://t.co/AA7r1O4Rgk
May 21st 2019, 9:05am
SwingTradeBot @SwingTradeBot
200 DMA Support today: $GNCA $C ... https://t.co/LjP7KUcNnp
May 21st 2019, 9:05am
mvonwhy @mvonwhy
$GNCA reverse split 8:1 effective May 22. https://t.co/3fw71s4dv6
May 21st 2019, 8:05am
SwingTradeBot @SwingTradeBot
200 DMA Support today: $GNCA ... https://t.co/LjP7KUcNnp
May 20th 2019, 2:05pm
FlyOnTheWallHQ @FlyOnTheWallHQ
RT @StockWatchHQ: MedGen $MDIN New Joint Venture With Genocea Biosciences $GNCA, Details To Come, Announcement Pending https://t.co/pycSFqi…
May 20th 2019, 10:05am
Biotrade_alert @Biotrade_alert
Trade Alert: Sold $GNCA at $0.67 with 7% Loss
May 20th 2019, 9:05am
InsiderBiotech @InsiderBiotech
$GNCA briefly before ASCO https://t.co/KSYuLow3zJ
May 20th 2019, 8:05am
BioBreakout @BioBreakout
Stocks I am watching for a potential trade... please add to the list with catalyst date in comments $ACHV $GNCA… https://t.co/JrxeJJHBqk
May 19th 2019, 9:05pm
StockWatchHQ @StockWatchHQ
MedGen $MDIN New Joint Venture With Genocea Biosciences $GNCA, Details To Come, Announcement Pending… https://t.co/Gc9QwSWl5e
May 19th 2019, 4:05pm
bulletin_en @bulletin_en
Reviewing bluebird bio Inc. $GNCA's results https://t.co/ksVb2oJfc3
May 19th 2019, 3:05pm
Opal_Chip @Opal_Chip
$GNCA Sold all – at breakeven. The ASCO abstract …meh. Could be something great in clinical responses, but if so,… https://t.co/Vp6utLQKUC
May 17th 2019, 3:05pm
OneMdcn @OneMdcn
$GNCA Genocea Biosciences (GNCA) Receives a Buy from H.C. Wainwright J. Pantginis PT $5.75 https://t.co/4yoOf3hsMX
May 17th 2019, 1:05pm
WheyPartyPeople @WheyPartyPeople
RT @syinvesting: $GNCA on watch list: #ASCO19 abstract showed 93% immune response in 3 pts treated with GEN-009 (Ph 1/2). Potential best-i…
May 16th 2019, 6:05pm
Madeforprofit1 @Madeforprofit1
$GNCA $1.89 cash in hand- I will hold my 50K ?????
May 16th 2019, 3:05pm
DmdMt24 @DmdMt24
@AceAnalyst what do you think about $gnca vs. $ntgn
May 16th 2019, 3:05pm
ramypandey @ramypandey
Realtime trade: bought some $gnca at .74
May 16th 2019, 2:05pm
Lin_ling_88 @Lin_ling_88
RT @GenoceaBio: $GNCA and $IOVA enter research collaboration to explore development of next-generation, neoantigen-targeted TIL products. #…
May 16th 2019, 2:05pm
ledgetop @ledgetop
@thejadedtrader Too bad. Hoping this is the beginning of the price improvement for $GNCA in months to come.
May 16th 2019, 2:05pm
AnthonyRuse @AnthonyRuse
@Benzinga That's what I'm talking about!! Get 'em $GNCA lol
May 16th 2019, 1:05pm
syinvesting @syinvesting
$GNCA on watch list: #ASCO19 abstract showed 93% immune response in 3 pts treated with GEN-009 (Ph 1/2). Potential… https://t.co/VwZNg4MbkK
May 16th 2019, 1:05pm
thejadedtrader @thejadedtrader
Closed out the remainder of my $GNCA. Very high burn rate and have a very long way to go with 011 asset. 93% immu… https://t.co/nxDTfHh8jJ
May 16th 2019, 1:05pm
YVR_Trader @YVR_Trader
Watch $GNCA ??? https://t.co/r1avppMiUF
May 16th 2019, 1:05pm
YVR_Trader @YVR_Trader
@ledgetop There you go..... $GNCA https://t.co/riOOzsJIn6
May 16th 2019, 1:05pm
GenoceaBio @GenoceaBio
$GNCA and $IOVA enter research collaboration to explore development of next-generation, neoantigen-targeted TIL pro… https://t.co/2anrVUCyN5
May 16th 2019, 1:05pm
YVR_Trader @YVR_Trader
RT @TraderTexMex: $GNCA Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumor-Infi…
May 16th 2019, 1:05pm
Ultra_Calls @Ultra_Calls
$GNCA Genocea Announces Research Collaboration With Iovance to Explore Development of Neoantigen-Targeted TIL (Tumo… https://t.co/xLb4FSzCsD
May 16th 2019, 1:05pm
TraderTexMex @TraderTexMex
$GNCA Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumo… https://t.co/YogKiCi9rL
May 16th 2019, 1:05pm
DZalkowitz @DZalkowitz
$IOVA is partnering with $GNCA to evaluate its ATLAS platform to see if it improves the efficacy of TIL therapy
May 16th 2019, 10:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.